Pharmaceutical Resources

Life sciences leaders like you must address changes and pressures along the pharmaceutical value chain. That’s why life sciences market experts from Optum® and Advisory Board came together once again to offer their take on 6 trends shaping pharmaceutical manufacturer strategies in 2024. Watch the on-demand webinar now.

Today, the most complex 5% of patients account for nearly 50% of overall costs. In this case study, Optum demonstrates the benefits clients have achieved when leveraging Specialty Fusion™ as their cross- benefit specialty drug management solution.

It is difficult to find one person who has not heard of the “opioid crisis,” referring to outpatients becoming addicted to opiates after being prescribed for various reasons. Learn how to prevent hospitalization-related iatrogenic dependence and reduce hospital return rates among older patients in this article.

Specialty pharmacies must adapt to drug pipeline and market shifts. This white paper presents 3 insights on future changes in specialty pharmacy models, including refining operations, pursuing value-based partnerships, and enhancing their value proposition. Access the full white paper for details.

In an August 2022 market research study, more than 600 medical science liaisons (MSLs) weighed in on virtual vs in-person engagements with potential key opinion leaders (KOLs); how it impacted their day-to day work and why even with more digital tools available.

Telehealth is transforming the life sciences industry, empowering patients and bridging healthcare disparities. This white paper explores emerging DTC models, innovative companies, and benefits of integrating virtual care into direct-to-consumer campaigns. Read the full white paper to learn more.

Drugs used to treat ADHD have been lacking for months now, leading to problems with access to prescription amphetamines and creating questions about the cause of the massive shortage. Download the article to know more.

Leading life sciences organizations like Moderna, AstraZeneca, and Thermo Fisher Scientific leverage AWS to remove the undifferentiated heavy lifting to focus more time and resources on bringing new and differentiated treatments to market. Read this eBook to learn how you can do the same.

Under traditional supply chain scenarios, physicians have little visibility into the volume and cost of the products and devices they consume. Read this paper to understand how a digitized supply chain creates clearer consumption visibility, supports better patient outcomes, and reduces waste and expense.